Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183197

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	322,528,000 EUR	—	—	—	—	—	—	283,509,000 EUR	—	—	—	—
Current assets	99,389,000 EUR	—	—	—	—	—	—	238,475,000 EUR	—	—	—	—
Non-current liabilities	292,285,000 EUR	—	—	—	—	—	—	293,500,000 EUR	—	—	—	—
Current liabilities	95,793,000 EUR	—	—	—	—	—	—	70,747,000 EUR	—	—	—	—
Revenue	—	—	—	—	22,668,000 EUR	—	—	—	—	9,030,000 EUR	—	—
Profit (loss)	—	—	—	—	116,875,000 EUR	116,875,000 EUR	92,086,000 EUR	—	—	92,086,000 EUR	—	—
Other comprehensive income	—	—	—	—	17,300,000 EUR	—	—	—	—	3,000,000 EUR	—	—
Comprehensive income	—	17,300,000 EUR	- EUR	- EUR	134,175,000 EUR	116,875,000 EUR	92,086,000 EUR	—	- EUR	89,086,000 EUR	- EUR	3,000,000 EUR